Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
[primary hyperoxaluria type 1]
Human
liver
peroxisomal
alanine
:
glyoxylate
aminotransferase
(
AGT
)
is
a
pyridoxal
5
'
-
phosphate
(
PLP
)
-
dependent
enzyme
that
converts
glyoxylate
into
glycine
.
AGT
deficiency
causes
primary
hyperoxaluria
type
1
(
PH
1
)
,
a
rare
autosomal
recessive
disorder
,
due
to
a
marked
increase
in
hepatic
oxalate
production
.
Normal
human
AGT
exists
as
two
polymorphic
variants
:
the
major
(
AGT
-Ma
)
and
the
minor
(
AGT
-Mi
)
allele
.
AGT
-Mi
causes
the
PH
1
disease
only
when
combined
with
some
mutations
.
In
this
study
,
the
molecular
basis
of
the
synergism
between
AGT
-Mi
and
F
152
I
mutation
has
been
investigated
through
a
detailed
biochemical
characterization
of
AGT
-Mi
and
the
Phe
(
152
)
variants
combined
either
with
the
major
(
F
152
I
-Ma
,
F
152
A
-Ma
)
or
the
minor
allele
(
F
152
I
-Mi
)
.
Although
these
species
show
spectral
features
,
kinetic
parameters
,
and
PLP
binding
affinity
similar
to
those
of
AGT
-Ma
,
the
Phe
(
152
)
variants
exhibit
the
following
differences
with
respect
to
AGT
-Ma
and
AGT
-Mi
:
(
i
)
pyridoxamine
5
'
-
phosphate
(
PMP
)
is
released
during
the
overall
transamination
leading
to
the
conversion
into
apoenzymes
,
and
(
ii
)
the
PMP
binding
affinity
is
at
least
200
-
1400
-
fold
lower
.
Thus
,
Phe
(
152
)
is
not
an
essential
residue
for
transaminase
activity
,
but
plays
a
role
in
selectively
stabilizing
the
AGT
-
PMP
complex
,
by
a
proper
orientation
of
Trp
(
108
)
,
as
suggested
by
bioinformatic
analysis
.
These
data
,
together
with
the
finding
that
apoF
152
I
-Mi
is
the
only
species
that
at
physiological
temperature
undergoes
a
time-dependent
inactivation
and
concomitant
aggregation
,
shed
light
on
the
molecular
defects
resulting
from
the
association
of
the
F
152
I
mutation
with
AGT
-Mi
,
and
allow
to
speculate
on
the
responsiveness
to
pyridoxine
therapy
of
PH
1
patients
carrying
this
mutation
.
Diseases
Validation
Diseases presenting
"and"
symptom
achondroplasia
adrenomyeloneuropathy
aniridia
carcinoma of the gallbladder
cutaneous mastocytosis
cystinuria
esophageal squamous cell carcinoma
harlequin ichthyosis
hodgkin lymphoma, classical
hydrocephalus with stenosis of the aqueduct of sylvius
kallmann syndrome
liposarcoma
locked-in syndrome
neonatal adrenoleukodystrophy
omenn syndrome
oral submucous fibrosis
pleomorphic liposarcoma
primary hyperoxaluria type 1
proteus syndrome
pyomyositis
pyruvate dehydrogenase deficiency
sneddon syndrome
triple a syndrome
trochlear dysplasia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom